🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/04/2018 56,62 56,92 56,59 56,75 +0,10% 0,57% 8.034.073
26/04/2018 57,08 57,34 56,40 56,69 -0,37% 1,64% 14.148.105
25/04/2018 57,16 57,18 56,23 56,90 -0,77% 1,65% 14.057.034
24/04/2018 57,64 58,21 57,03 57,34 -0,27% 2,04% 13.974.975
23/04/2018 57,30 57,84 56,71 57,49 +2,41% 1,98% 20.767.587
20/04/2018 56,16 56,56 55,97 56,14 +0,32% 1,04% 10.109.951
19/04/2018 56,22 56,60 55,74 55,95 -0,48% 1,53% 11.041.204
18/04/2018 56,69 56,89 55,91 56,22 -0,59% 1,73% 11.779.730
17/04/2018 57,10 57,21 56,26 56,56 +1,06% 1,67% 16.070.451
16/04/2018 55,12 56,54 54,55 55,96 +2,59% 3,60% 23.627.998
13/04/2018 54,47 54,70 54,05 54,55 +0,76% 1,21% 10.536.278
12/04/2018 54,01 54,57 53,57 54,14 +0,96% 1,86% 12.511.967
11/04/2018 53,49 53,95 53,33 53,63 -0,51% 1,16% 9.445.834
10/04/2018 54,08 54,19 53,47 53,90 +0,59% 1,32% 13.481.891
09/04/2018 52,48 54,79 52,06 53,59 +5,25% 5,20% 24.352.376
06/04/2018 51,79 52,08 50,48 50,92 -2,15% 3,10% 13.100.838
05/04/2018 52,54 52,84 51,95 52,03 -0,02% 1,71% 13.074.638
04/04/2018 51,02 52,19 50,95 52,04 +0,83% 2,41% 9.330.030
03/04/2018 50,90 51,67 50,41 51,61 +1,54% 2,47% 9.688.341
02/04/2018 51,91 52,15 50,53 50,83 -2,20% 3,11% 14.041.104
29/03/2018 52,82 52,87 51,98 51,98 -1,13% 1,70% 10.218.524
28/03/2018 51,57 52,81 51,55 52,57 +2,49% 2,44% 13.302.788
27/03/2018 51,52 52,06 51,02 51,29 -0,54% 2,02% 16.956.535
26/03/2018 51,57 51,68 50,54 51,56 +1,18% 2,20% 10.448.770
23/03/2018 51,83 52,20 50,90 50,96 -1,31% 2,52% 12.408.634
22/03/2018 51,76 52,46 51,56 51,64 -1,04% 1,75% 13.387.990
21/03/2018 52,25 52,75 51,93 52,19 +0,09% 1,57% 10.489.746
20/03/2018 52,24 52,42 51,87 52,14 +0,02% 1,06% 8.153.440
19/03/2018 53,11 53,13 51,76 52,13 -1,87% 2,59% 12.391.762
16/03/2018 52,66 53,29 52,56 53,12 +0,76% 1,40% 22.010.620